Premium
Rhesus anti‐D immunoglobulin in chronic autoimmune neuropathy
Author(s) -
Jager A. E. J.,
Hazenberg C. A. M.,
Hoeven J. H.
Publication year - 1998
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1998.tb07380.x
Subject(s) - medicine , multifocal motor neuropathy , antibody , autoimmune disease , chronic inflammatory demyelinating polyneuropathy , immunology , peripheral neuropathy , immunoglobulin g , diabetes mellitus , endocrinology , mismatch negativity , electroencephalography , psychiatry
Objective – To investigate the effect of Rhesus anti‐D immunoglobulin (anti‐D) in patients with an autoimmune demyelinating neuropathy. Material and methods – Three patients with an autoimmune mediated neuropathy received 1000 IU anti‐D weekly for 2 months. Results – Two patients worsened gradually during the treatment and 1 remained unchanged. Conclusion – Rhesus anti‐D immunoglobulin has no beneficial effect in patients with autoimmune neuropathy.